Back
Calidi Biotherapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
CLDI
Calidi Biotherapeutics
Last Price:
$0.61
Seasonality Move:
-36.42%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CLDI is experiencing slight buying pressure.
Calidi Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.65 | Sell |
| 20-day SMA: | 0.41 | Buy |
| 50-day SMA: | 0.39 | Buy |
| 200-day SMA: | 0.95 | Sell |
| 8-day EMA: | 0.59 | Buy |
| 20-day EMA: | 0.48 | Buy |
| 50-day EMA: | 0.45 | Buy |
| 200-day EMA: | 2.19 | Sell |
Calidi Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 58.75 | Buy |
| Chaikin Money Flow: | 979234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.19 - 0.59) | Buy |
| Bollinger Bands (100): | (0.32 - 0.72) | Buy |
Calidi Biotherapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Calidi Biotherapeutics Stock
Is Calidi Biotherapeutics Stock a Buy?
-
Calidi Biotherapeutics share price is 0.62 while CLDI 8-day simple moving average is 0.65, which is a Sell signal.
-
The stock price of CLDI is 0.62 while Calidi Biotherapeutics 20-day SMA is 0.41, which makes it a Buy.
-
Calidi Biotherapeutics 50-day simple moving average is 0.39 while CLDI share price is 0.62, making it a Buy technically.
-
CLDI stock price is 0.62 and Calidi Biotherapeutics 200-day simple moving average is 0.95, creating a Sell signal.
CLDI Technical Analysis vs Fundamental Analysis
Sell
39
Calidi Biotherapeutics (CLDI)
is a Sell
Is Calidi Biotherapeutics a Buy or a Sell?
-
Calidi Biotherapeutics stock is rated a SellThe current Calidi Biotherapeutics [CLDI] share price is $0.62. The Score for CLDI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Calidi Biotherapeutics Stock Info
Market Cap:
19.6M
Price in USD:
0.62
Share Volume:
3.1M
Calidi Biotherapeutics 52-Week Range
52-Week High:
3.89
52-Week Low:
0.20
Sell
39
Calidi Biotherapeutics (CLDI)
is a Sell
Calidi Biotherapeutics Share Price Forecast
-
What is the Calidi Biotherapeutics stock price today?The Calidi Biotherapeutics stock price is 0.62 USD today.
-
Will CLDI stock go up or go down?Calidi Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Calidi Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Calidi Biotherapeutics is overvalued.
Is Calidi Biotherapeutics Stock a Buy?
-
Calidi Biotherapeutics share price is 0.62 while CLDI 8-day exponential moving average is 0.59, which is a Buy signal.
-
The stock price of CLDI is 0.62 while Calidi Biotherapeutics 20-day EMA is 0.48, which makes it a Buy.
-
Calidi Biotherapeutics 50-day exponential moving average is 0.45 while CLDI share price is 0.62, making it a Buy technically.
-
CLDI stock price is 0.62 and Calidi Biotherapeutics 200-day simple moving average is 2.19, creating a Sell signal.
Fundamental Analysis of Calidi Biotherapeutics
Is Calidi Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.13 per share.
Technical Analysis of Calidi Biotherapeutics
Should I short Calidi Biotherapeutics stock?
-
CLDI Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Calidi Biotherapeutics is a Buy
-
Calidi Biotherapeutics Relative Strength Index (RSI) is 58.75, which suggest Calidi Biotherapeutics is overbought
-
The Bollinger Bands (25) for Calidi Biotherapeutics is (0.19 - 0.59), which suggest Calidi Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Calidi Biotherapeutics is (0.32 - 0.72), which suggest Calidi Biotherapeutics is a Buy
* Calidi Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.